Skip to main content
Clinical Trials/NCT03781973
NCT03781973
Completed
Not Applicable

Bridging the Gap to Optimize Care and Outcomes for Youth With Diabetes Between Pediatric and Adult Diabetes Care

The Hospital for Sick Children5 sites in 1 country484 target enrollmentJune 1, 2019
ConditionsType1diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type1diabetes
Sponsor
The Hospital for Sick Children
Enrollment
484
Locations
5
Primary Endpoint
HbA1c
Status
Completed
Last Updated
last year

Overview

Brief Summary

Adolescents with type 1 diabetes face particular challenges related to having a chronic illness that requires daily intensive self-management and medical follow-up during a period when their social, developmental, educational, and family situations are in flux. When transitioning from pediatric to adult care, over a third of youth have a care gap of >6 months. During this vulnerable period youth are at risk for acute life-threatening complications such as diabetic ketoacidosis, and for poor glycemic control, which confers an increased risk of chronic diabetes complications. Gaps in care may be a result of deficiencies in transition processes causing some young people to be poorly prepared for adult care and dissatisfied with the transition process. Ineffective transition can lead to decreased frequency of diabetes visits and an increased risk of adverse events in young adulthood. Further, risk factors such as psychiatric comorbidity and behavioural problems in adolescents with type 1 diabetes are associated with poor outcomes in early adulthood. Quality improvement initiatives can be designed to optimize care processes such as referral systems to adult diabetes providers.

Our overall objective is to optimize care and outcomes for youth with diabetes as they transition to adult care.

Specific Aim 1: To improve glycemic control in youth around the time of transition from pediatric to adult diabetes care Specific Aim 2: To evaluate the fidelity and quality of a quality improvement intervention designed to improve transition care processes and to identify contextual factors associated with variation in outcomes.

Registry
clinicaltrials.gov
Start Date
June 1, 2019
End Date
December 31, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Rayzel Shulman

Scientist Track Investigator

The Hospital for Sick Children

Eligibility Criteria

Inclusion Criteria

  • All youth with a clinical diagnosis of type 1 diabetes followed at participating centres at the time of their final pediatric clinic visit between Jan 1, 2018 and Dec 31,
  • Participants will be transitioning to Adult Care (ages \~16-19 yrs).
  • Capacity to read and understand English (we estimate that \>95% of participants will fulfill this requirement).
  • Capacity to consent for themselves.

Exclusion Criteria

  • Individuals with non-type 1 diabetes.
  • Individuals with type 1 diabetes who move out of Ontario within 12 months after their final pediatric visit.
  • Individuals with type 1 diabetes who do not have the capacity to consent for themselves.

Outcomes

Primary Outcomes

HbA1c

Time Frame: HbA1c value up to 12 months after the final pediatric visit.

Hemoglobin A1c

Secondary Outcomes

  • Time from the final pediatric visit to the first adult diabetes visit(Time in months up to 12 months after the final pediatric visit)
  • Number of Diabetes-related admissions, ED visits, death(number of occurrences up to12 months after the final pediatric visit.)

Study Sites (5)

Loading locations...

Similar Trials